not losing weight on semaglutide week 2 7 Reasons You Aren't Weight Loss Drugs 10 Reasons You're Not Losing

Emerging evidence suggests GLP-1 receptor agonists are associated with increased gallstone risk, with clinical trials showing gallbladder disorders in approximately 2.6% of patients on semaglutide versus 1.2% on placebo

You can also create side-by-side progress pictures for a visual representation of how your body is changing by following the workout and nutrition plans

Understanding the specific storage requirements for your prescribed GLP-1 medication is crucial for treatment success

Certain individuals may be at higher risk of experiencing gout whilst taking Wegovy, particularly those with pre-existing risk factors